Drug Profile
Fentanyl orally-dissolving film - NAL Pharma
Alternative Names: NAL 1239Latest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator NAL Pharma
- Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer pain
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for clinical-Phase-Unknown development in Cancer-pain in Unknown (Sublingual, Film)
- 12 Dec 2016 Chemical structure information added
- 29 Nov 2016 Fentanyl orally-dissolving film - NAL Pharma is available for licensing as of 29 Nov 2016. http://www.nalpharma.com/licensing.php?id=4&lang=en